Quyen D. Chu

4.1k total citations
134 papers, 2.4k citations indexed

About

Quyen D. Chu is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Quyen D. Chu has authored 134 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 35 papers in Surgery and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Quyen D. Chu's work include Breast Cancer Treatment Studies (19 papers), Global Cancer Incidence and Screening (15 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Quyen D. Chu is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Global Cancer Incidence and Screening (15 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Quyen D. Chu collaborates with scholars based in United States, China and Vietnam. Quyen D. Chu's co-authors include Benjamin D.�L. Li, Harold J. Wanebo, Michael P. Vezeridis, Lester W. Johnson, John F. Gibbs, Roger H. Kim, Michael P. Kosty, Helen K. Chew, William J. Gradishar and John Pippen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Quyen D. Chu

126 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quyen D. Chu United States 25 1.0k 648 384 350 345 134 2.4k
Laurie Elit Canada 32 874 0.8× 600 0.9× 303 0.8× 590 1.7× 260 0.8× 143 3.6k
F. Marc Stewart United States 27 971 0.9× 616 1.0× 155 0.4× 387 1.1× 304 0.9× 81 2.8k
Stephanie V. Blank United States 26 1.3k 1.3× 493 0.8× 141 0.4× 706 2.0× 388 1.1× 165 3.4k
Rob C.M. Pelger Netherlands 32 1.0k 1.0× 612 0.9× 125 0.3× 686 2.0× 679 2.0× 131 3.0k
Petronella B. Ottevanger Netherlands 30 1.2k 1.2× 273 0.4× 300 0.8× 175 0.5× 327 0.9× 129 2.5k
W. Gregory United Kingdom 20 1.4k 1.4× 292 0.5× 786 2.0× 734 2.1× 468 1.4× 37 3.6k
Christopher C. McConkey United Kingdom 24 1.2k 1.2× 1.0k 1.6× 142 0.4× 290 0.8× 587 1.7× 43 3.3k
Heather B. Neuman United States 29 1.1k 1.1× 924 1.4× 195 0.5× 124 0.4× 338 1.0× 134 2.5k
Katherine Van Loon United States 21 956 0.9× 270 0.4× 129 0.3× 201 0.6× 267 0.8× 126 1.7k
Karina Braga Ribeiro Brazil 32 729 0.7× 1.1k 1.7× 108 0.3× 576 1.6× 481 1.4× 92 3.3k

Countries citing papers authored by Quyen D. Chu

Since Specialization
Citations

This map shows the geographic impact of Quyen D. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quyen D. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quyen D. Chu more than expected).

Fields of papers citing papers by Quyen D. Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quyen D. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quyen D. Chu. The network helps show where Quyen D. Chu may publish in the future.

Co-authorship network of co-authors of Quyen D. Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Quyen D. Chu. A scholar is included among the top collaborators of Quyen D. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quyen D. Chu. Quyen D. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chu, Quyen D., et al.. (2024). Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system?. Surgical Endoscopy. 38(5). 2857–2870. 3 indexed citations
4.
Danos, Denise, et al.. (2023). Is There Really a Difference in Outcomes between Men and Women with Hepatocellular Cancer?. Cancers. 15(11). 2892–2892. 2 indexed citations
5.
Lairmore, Terry C., et al.. (2022). A Rare Case of Pure Primary Large Cell Neuroendocrine Carcinoma of the Gallbladder. SHILAP Revista de lepidopterología. 2022. 1–4.
6.
Gralow, Julie R., Fredrick Chite Asirwa, Ami S. Bhatt, et al.. (2020). Recommendations from the ASCO Academic Global Oncology Task Force. JCO Global Oncology. 6(6). 1666–1673. 11 indexed citations
7.
Chu, Quyen D., Mei‐Chin Hsieh, John Lyons, & Xiao‐Cheng Wu. (2020). 10-Year Survival after Breast-Conserving Surgery Compared with Mastectomy in Louisiana Women with Early-Stage Breast Cancer: A Population-Based Study. Journal of the American College of Surgeons. 232(4). 607–621. 20 indexed citations
8.
Chu, Quyen D., et al.. (2016). Two decades of humanitarian surgical outreach and capacity building in Kurdistan.. PubMed. 101(10). 33–41. 4 indexed citations
10.
Chu, Quyen D., et al.. (2013). Effect of January Vacations and Prior Night Call Status on Resident ABSITE Performance. Journal of surgical education. 70(6). 720–724. 15 indexed citations
11.
Chu, Quyen D., Gazi B. Zibari, & Hung S. Ho. (2011). Surgical volunteerism in Vietnam: surgeons and educators strengthen the U.S.-Vietnam relationship.. PubMed. 96(11). 12–8. 1 indexed citations
12.
Chu, Quyen D., Gary V. Burton, Jonathan Glass, Mark H. Smith, & Benjamin D.�L. Li. (2010). Impact of Race and Ethnicity on Outcomes for Estrogen Receptor-Negative Breast Cancers: Experience of an Academic Center with a Charity Hospital. Journal of the American College of Surgeons. 210(5). 585–592. 12 indexed citations
13.
Kleiner, Heather E., K. C. Prasad, Carol Meschonat, et al.. (2009). Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. Journal of Experimental & Clinical Cancer Research. 28(1). 5–5. 21 indexed citations
14.
Chu, Quyen D., et al.. (2008). Hypoxia induces CXCR4 overexpression in pancreatic cancer cells. Cancer Research. 68. 4472–4472. 1 indexed citations
15.
Li, Benjamin D.�L., et al.. (2007). Elevated Levels of Chemokine Receptor CXCR4 in HER-2 Negative Breast Cancer Specimens Predict Recurrence. Journal of Surgical Research. 141(1). 53–59. 51 indexed citations
16.
Li, Benjamin D.�L., Jie Li, Arrigo De Benedetti, et al.. (2007). A novel suicide gene therapy targeting the overexpression of eukaryotic initiation factor 4E improves survival in a rat peritoneal carcinomatosis model. Surgery. 142(2). 270–275. 2 indexed citations
17.
Chu, Quyen D., Carol Meschonat, Herbert Yu, et al.. (2006). High eIF4E, VEGF, and Microvessel Density in Stage I to III Breast Cancer. Annals of Surgery. 243(5). 684–692. 48 indexed citations
18.
Chu, Quyen D., Thelma C. Hurd, Gabor Markus, et al.. (2004). Overexpression of Urinary Plasminogen Activator (uPA) Protein and mRNA in Thyroid Carcinogenesis. Diagnostic Molecular Pathology. 13(4). 241–246. 14 indexed citations
19.
Wiseman, Sam M., Wesley L. Hicks, Quyen D. Chu, & Nestor Rigual. (2002). Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surgical Oncology. 11(3). 137–142. 34 indexed citations
20.
Simon, Bruce J., et al.. (1998). Delayed Hemothorax after Blunt Thoracic Trauma. PubMed. 45(4). 673–676. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026